ImmuPharma (LON:IMM) Trading 8.4% Higher – Here’s Why
by Mitch Edgeman · The Markets DailyImmuPharma plc (LON:IMM – Get Free Report) was up 8.4% during mid-day trading on Thursday . The stock traded as high as GBX 5.05 and last traded at GBX 5.04. Approximately 3,112,903 shares changed hands during mid-day trading, a decline of 12% from the average daily volume of 3,528,083 shares. The stock had previously closed at GBX 4.65.
ImmuPharma Trading Up 8.4%
The company has a market cap of £31.45 million, a P/E ratio of -5.66 and a beta of 3.02. The firm’s 50 day moving average price is GBX 6.38 and its 200-day moving average price is GBX 7.84.
About ImmuPharma
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.